Skip to content

Clinical trials

Phase 2 Liver Diseases trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Country / region: Puerto Rico Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20161
20191
20213
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.1
Bristol-Myers Squibb1
Enyo Pharma1
Genentech, Inc.1
Merck Sharp & Dohme LLC1
Mirum Pharmaceuticals, Inc.1
National Institute of Allergy and Infectious Diseases (NIAID)1
Sagimet Biosciences Inc.1
ZymoGenetics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases9
Non-alcoholic Fatty Liver Disease6
Fatty Liver4
Digestive System Diseases2
Hepatitis C2
Carcinoma, Hepatocellular1
Digestive System Neoplasms1
Fibrosis1
HIV Infections1
Hepatitis C, Chronic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.